Marksman51
06 Jun 2018
Re: IMM Ripley, below is my post from 24/1/2018 selling IMMThe heading was Re: losersRe: losersSold two stocks, a decliner and a loser.BIFF Sold , some profit takenIMM sold with a £90 loss crystallised So all is on record. I don’t hide, I don’t lie. If I make a mistake then it’s a genuine error.Now, PLEASE, do not ask me again questions like this. Too time-consuming for me. I’m not really interested. It’s not my problem. I move on, plenty of other things to do. Thanks.Dr M
Marksman51
06 Jun 2018
Re: IMM Ripley, I live in the fast lane. You’re not supposed to keep up with me, you can’t.I sold this share in January when the uptrend broke down. That’s my Sell strategy. I must’ve mentioned it along with other sales under a general heading. The reason I’m not being more specific because the amount of money involved was minimal thus not worth mentioning as such.A lot of the shares I’m buying in bulk are small entry amounts and when the uptrend breaks down and I have to sell, my losses of around £50-80 are NOT worth mentioning. I mean I’m not hiding anything, it’s just not worth it.My advice to you, if I may, is keep going and don’t concern yourself with beer tokens. And try to establish an effective strict stop loss strategy for your fallers in future. Don’t allow losses to accumulate. This is well worth doing, I promise you with my hand on heart.Good luck, as always.Dr M
Marksman51
06 Jun 2018
Re: my system dr Good to know you do hold shares long term.I always have cash in my account ALWAYS. Minimum is 4% of my portfolio is in cash. Currently it is around 9%. So I’m always ready and able to purchase a new share if the opportunity arises.Some people think it’s a waste holding cash; I disagree. It is imperative that I’m able to buy without having to sell profitable shares.Just meDr M
Marksman51
06 Jun 2018
GAN , RNS, Please Read Please read. H2 is the time when the revenues will materially increase ie like I said all along this share has a timeframe of 6-9 months. We’ll see what happens from now. There needs to be a regular newsflow for this share to carry on doing well for the next few months. It is a BUY if you’re prepared for the volatility in sp and if you’re prepared to ignore detractors like iamsharecrazy, Loadsadough, Lebehnon...etcDYOR Good luck Dr MGAN06 Jun 2018 10:58:16GAN PLCRNS Number : 5000QGAN PLC06 June 2018 LONDON STOCK EXCHANGE (LSE): GAN | IRISH STOCK EXCHANGE (ISE): GAME Update on Legalization of US Internet Sports BettingRe-confirms H2 launch of Internet sports betting in the US London & Dublin HTMLPIPESYMBOL June 6, 2018: GAN plc ("GAN" or the "Company"
, an award-winning developer and supplier of enterprise-level B2B Internet gaming software, services and online gaming content in the United States, today provides an update following the decision of the Supreme Court of the United States ("SCOTUS" to overturn the previous Federal US prohibition on sports betting enshrined with the Professional and Amateur Sports Protection Act 1992 ("PASPA". Recent press reports have speculated that certain New Jersey casinos may be prohibited from launching Internet sports betting due to their ownership of or other association with US sports teams ("Issue". The Company re-confirms it is preparing to launch Internet sports betting in both New Jersey and Pennsylvania for its clients in H2 and further confirms the Company has investigated the reported Issue with its clients and does not currently expect any impact on GAN's plans to launch sports betting in H2. Sports betting will be delivered as an integrated extension into GAN's enterprise software platform and GAN will participate in the material incremental sports betting revenues. These incremental revenues are expected to be material for GAN in H2. Management Commentary Dermot Smurfit, CEO of GAN commented: "Online sports betting 'go-live' preparations are well advanced and we remain confident in launching as soon as reasonably possible in H2." For further information please contact: GANUS Investors: The Equity GroupDermot SmurfitAdam PriorChief Executive [email protected]+44 (0) 20 7292 [email protected] UK & Ireland Investors: Walbrook PR Paul Cornelius [email protected] +44 20 7933 8780 Davy (Nominated Adviser, ESM Adviser and Joint Broker) John Frain / Barry Murphy +353 1 679 6363 Liberum (Joint Broker) Neil Patel / Cameron Duncan +44 (0) 20 3100 2000 GAN HTMLPIPESYMBOL Overview GAN is a leading B2B supplier of Internet gaming enterprise software-as-a-service solutions to the US land-based casino Industry. GAN is listed on the ESM Market of the Irish Stock Exchange and the AIM Market of the London Stock Exchange under the ticker: GAN The Company has developed an Internet gaming enterprise software system, GameSTACK™, which it licenses principally to land-based US casino operators as a turnkey technology solution for both regulated real-money and/or virtual Simulated Gaming. GAN has fourteen (14) casino operators as clients of Simulated Gaming coast-to-coast across the US and Internationally; two (2) clients of real money Regulated Gaming in New Jersey; one (1) client of real money Regulated Gaming in Pennsylvania and ten (10) clients of real money Regulated Gaming in Europe. The Internet Gaming System, developed in London under a UK Gambling Commission license, is certified to the highest technical standards currently required by gaming regulators. In January 2018 GAN announced a strategic partnership with SBTECH, a leading European B2B sports betting technology provider. In April 2017 GAN was granted a Casino Service Industry Enterprise license by the New Jersey Division of
lebehnon
06 Jun 2018
my system dr i have long term core holdings 30 the rest are trades using spare cash - like to have cash available - the trades can be cut if the markets look bad so take profits - also cut them if they do not perform.
Ripley94
06 Jun 2018
Re: IMM You do not link your posts Marksman so not easy to keep up.Your stated style suggests you must of sold this share if so when ?Did you post your sale ?
Moonsurfer
06 Jun 2018
Re: MTCH M51,hope your purchase is not the kiss of death as I recently bought on the recovery and I'm up 6%.Moon
Marksman51
06 Jun 2018
Re: ETO Dr LebWhat I meant is this. When I buy a share say at 100p, I set a stop loss target say at 92p. Thus, I do sell shares but only if they hit my stop loss target. It may appear I’m trading but I’m not, I’m a forced seller. But unlike traders I don’t set a sell target. I hope and expect the share to continue to rise indefinitely, may be reach £5, so No Sell Target. Thus, crucially, my intention at the point of purchase is to invest NOT to trade.Traders, in contrast, buy at 100p just like me, stop loss like me at 92p but they set a Sell target of 115p and they sell when this is hit within say 3 weeks if they’re lucky. That’s trading NOT investing. That’s what you often do. You hardly have any share in your portfolio that you hold for more than 2 months or so. This is my impression of you. Evidence: Just look at Your American shares you mentioned last night, you’re in and out like a yo-yo, every 2 days !!!LolDr M
lebehnon
06 Jun 2018
ETO Dr ticking up will be adding today - Dr am not a 12% trader. You have a load of sells with £100 losses not sure if you have been hit with profit warnings on some that you have added to - imagine this has happened. You do sell some of yours early - I like to sell some at 30 - 40% if markets are slackening then add back. My stage 4 risers can sell quick if am in profit and think they are stalling may not have reached stage 2. I know that we are in a bull market that is a wary one because we have been in it for so long and don't think it can last. Having some cash up your sleeve is the best policy imv.
Marksman51
06 Jun 2018
MACF WARNING this post is not about a little resources company. So skip now if you wish.[link] Macfarlane Group. The sp chart in link above looks good for a “rising” share. This co is engaged in designing, manufacturing and distribution of packaging products which include self-adhesive labels and warehousing. It operates in the UK, Europe and USA.Market Cap of £170 million, profits up from £7.8 to £9.3 million in 2017, dividend yield of 1.94%, PE of 14, PEG of 1.2 and EPS growth of 12%. Dividend payment day is tomorrow, significance??This may not turn out to be a fast rising share, just a steady Eddie, me thinks. But I like that sometimes.My rating is 2* Solid Buy. Just my opinion, not advice to buy or otherwise. DYOR Dr M
Nige the snake
06 Jun 2018
Re: portfolio showing over 12% profit now in... should say in 4 months stated with this in feb
Nige the snake
06 Jun 2018
portfolio showing over 12% profit now in 3 months 36,403.40 40,781.00 +4,377.60 +12.03 GBPOverall Total 36,403.40 40,781.00 +4,377.60 +12.03 GBPOverall GBP Total 36,403.40 40,781.00 +4,377.60 +12.03NB.Your cash entries are now held in Other A
Marksman51
06 Jun 2018
Re: OXB RNS [link] bought this as a “rising” share a while ago and topped up last week. The sp chart in link above. Up 17% this morning.Looks like it’ll continue to rise and make people money.BuyDYORDr M
Marksman51
06 Jun 2018
Re: Twitter up 5% today Well said all round Bob.I sometimes like to joke and tease people a bit.Excellent stuff from you. ThanksDr M
loadsadough
06 Jun 2018
OXB RNS I hope you all have OXB by now.OXB and Axovant Sciences Licence AgreementRNSRNS Number : 4166QOxford Biomedica PLC06 June 2018 Oxford BioMedica and Axovant Sciences enter into a $842.5 Million Exclusive Worldwide Licence Agreement for OXB-102 for the Treatment of Parkinson's DiseaseUnder the terms of the agreement, Oxford BioMedica will receive a $30 million upfront payment (approximately £22 million) including $5 million as pre-payment for manufacturing activities related to OXB-102, now renamed, AXO-Lenti-PD. Oxford BioMedica is also eligible to receive $55 million upon the achievement of specified development milestones and $757.5 million upon the achievement of specified regulatory and sales milestones, with 7% to 10% tiered royalties on net sales of AXO-Lenti-PD.Loadsadough
